Long‐Term Results Following Switch From Abciximab to Eptifibatide During Percutaneous Coronary Intervention

BACKGROUND: The usage of platelet glycoprotein (GP) IIb/IIIa receptor inhibitors improves the outcome during high‐risk percutaneous coronary interventions (PCI). The aim of this study was to evaluate the long‐term effects after a planned switch from abciximab to eptifibatide during PCI. HYPOTHESIS:...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cardiol
Main Authors: Koutouzis, Michael, Lagerqvist, Bo, Oldgren, Jonas, Åkerblom, Axel, Wahlin, Magnus, Karlsson, Thomas, Albertsson, Per, Matejka, Göran, Grip, Lars
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley Periodicals, Inc. 2010
Assuntos:
Clinical Investigations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6653077/
https://ncbi.nlm.nih.gov/pubmed/21089113
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.20814
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados